% of Cases treated with Teletherapy
| Country average (population) | Country average (country) | England | Scotland | Northern Ireland | Wales | Republic of Ireland | |
|---|---|---|---|---|---|---|---|
| All invasive xnmsc | 20.2% | 20.2% | 20.2% | NA | NA | ||
| All xnmsc 0-24 | 12.3% | 12.3% | 12.3% | NA | NA | ||
| All xnmsc 25-59 | 22.5% | 22.5% | 22.5% | NA | NA | ||
| All xnmsc 60-79 | 22.6% | 22.6% | 22.6% | NA | NA | ||
| All xnmsc 80+ | 12.0% | 12.0% | 12.0% | NA | NA | ||
| Haematology | 9.8% | 9.8% | 9.8% | NA | NA | ||
| Head and Neck | 59.5% | 59.5% | 59.5% | NA | NA | ||
| Lower GI | 13.1% | 13.1% | 13.1% | NA | NA | ||
| Upper GI | 19.2% | 19.2% | 19.2% | NA | NA | ||
| HPB | 2.1% | 2.1% | 2.1% | NA | NA | ||
| Trachea, Bronchus & Lung | 26.9% | 26.9% | 26.9% | NA | NA | ||
| Melanoma of skin | 0.9% | 0.9% | 0.9% | NA | NA | ||
| Breast | 37.7% | 37.7% | 37.7% | NA | NA | ||
| Prostate | 39.1% | 39.1% | 39.1% | NA | NA | ||
| Cervix | 9.7% | 9.7% | 9.7% | NA | NA | ||
| Other Female Genitals | 19.6% | 19.6% | 19.6% | NA | NA | ||
| Kidney | 5.6% | 5.6% | 5.6% | NA | NA | ||
| Bladder | 17.7% | 17.7% | 17.7% | NA | NA | ||
| Brain and CNS | 46.5% | 46.5% | 46.5% | NA | NA | ||
| Thyroid & other endocrine glands | 7.5% | 7.5% | 7.5% | NA | NA | ||
| CUP | 12.0% | 12.0% | 12.0% | NA | NA | ||
| Other invasive cancer | 13.2% | 13.2% | 13.2% | NA | NA | ||
| Breast in situ | 32.5% | 32.5% | 32.5% | NA | NA | ||
| Cervix in situ | 0.0% | 0.0% | 0.0% | NA | NA | ||
| Other tumours | 1.1% | 1.1% | 1.1% | NA | NA | ||
| Non-Melanoma Skin Cancer | 2.0% | 2.0% | 2.0% | NA | NA |